Prognostic value of the duke activity Status Index Questionnaire in predicting mortality in patients with chronic

Aldair Darlan Santos-de-Araújo1, Daniela Bassi-Dibai2, Izadora Moraes Dourado1

  • 1Cardiopulmonary Physiotherapy Laboratory, Universidade Federal de São Carlos, Federal University of Sao Carlos Rodovia Washington Luiz, São Carlos, 13565-905, SP, Brazil.

PubMed

Insights

A Duke Activity Status Index (DASI) questionnaire score of 23 or less strongly predicts mortality in chronic heart failure (CHF) patients over 36 months. This threshold aids in risk stratification for CHF management.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • The Duke Activity Status Index (DASI) questionnaire is utilized for assessing functional capacity in chronic heart failure (CHF) patients.
  • While its prognostic value is recognized, optimal threshold scores for predicting mortality require further investigation.

Purpose of the Study:

  • To determine optimal DASI questionnaire threshold values for predicting mortality in a CHF cohort.
  • To evaluate mortality rates using identified DASI questionnaire thresholds.

Main Methods:

  • Prospective cohort study with 36-month follow-up in 124 CHF patients.
  • Utilized Receiver Operating Characteristic (ROC) curve analysis and Kaplan-Meier survival analysis.
  • Assessed DASI questionnaire scores, pulmonary function, and echocardiography.

Main Results:

  • A DASI questionnaire score threshold of ≤/>23 was identified as a significant predictor of 36-month mortality in the CHF cohort.
  • Kaplan-Meier analysis confirmed the strong predictive capacity of this threshold.

Conclusions:

  • A DASI questionnaire score of ≤/>23 effectively discriminates 36-month mortality risk in CHF patients, particularly those with reduced ejection fraction.
  • Key mortality risk factors identified include age, ejection fraction, DASI score, and digoxin use.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
Heart Failure V: Nursing Interventions01:30

Heart Failure V: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1